Global Fluorescence Guided Surgery System Market 2024-2031

Global Fluorescence Guided Surgery System Market 2024-2031

Fluorescence Guided Surgery System Market Size, Share & Trends Analysis Report by Type (SPY System, PDE System, and VS3 Iridium Systems), by Surgery (Open Surgery, and Laparoscopy/Endoscopy), and by Application (Cancer Surgeries, Cardiovascular Surgeries, and Others) Forecast Period (2024-2031)

Fluorescence-guided surgery system market is anticipated to grow at a CAGR of 15.7% during the forecast period (2024-2031). Fluorescence-guided surgery (FGS) is an optical imaging technique that uses invisible light to create a real-time image of the surgical area during a procedure. This helps surgeons identify and remove or preserve anatomical features like tumors, cancer cells, and nerves with greater precision and accuracy. FGS can also reduce the risk of damaging healthy tissue, which can shorten the operation and decrease the need for repeat surgeries.

Market Dynamics

A growing number of surgeries

The number of surgical procedures, healthcare spending, and regulatory approvals are all expected to increase, which will drive growth in the global FGS system market. Improved fluorescent probes that are extremely selective to malignant cells or target tissues are the result of research and development. During operations, these probes help doctors see the surgical site more clearly. Clinical evidence demonstrates that FGS improves patient outcomes, which motivates medical facilities to implement it during surgeries.

A rising number of research and development

Research and development activities result in the creation of ever-more-advanced fluorescent probes that are extremely selective to malignant cells or other target tissues. With the use of these probes, doctors can see the surgical site more clearly while performing their procedures. An expanding clinical data collection shows that FGS has improved patient outcomes. The use of these technologies by healthcare facilities is encouraged by these findings.

Market Segmentation

Based on type, the market is sub-segmented into SPY system, PDE system, and VS3 iridium system.

Based on surgery, the market is bifurcated into open surgery and laparoscopy/endoscopy.

Based on application, the market is segmented into cancer surgeries, cardiovascular surgeries, and others (gastrointestinal).

SPY System is Projected to Emerge as the Largest Segment

The growing prevalence of cardiac problems has led to a dominant market for the SPY system, which employs FGS to enhance surgical outcomes. Similar to the SPY system, FGS systems leverage particular biological targets and real-time tissue perfusion monitoring during surgery. With the SPY system, surgeons can perform procedures with minimal difficulties and improve patient outcomes. Hence, these systems hold a major share in the global market.

Regional Outlook

The global fluorescence-guided surgery system market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific countries to serve as a clinical research center

The Asia-Pacific region serves as a center for clinical research and FGS collaboration, bringing together academic institutions and medical providers to conduct technology development and clinical trials.

Policies and regulations regarding reimbursement for fluorescence-guided procedures differ based on the particular application and healthcare provider across the region.

North America Holds Major Market Share

The high prevalence of chronic diseases including cancer and cardiovascular disease, as well as the high level of awareness and demand for sophisticated surgical treatments across the region, are the key contributors to the regional market share. Moreover, the advanced healthcare infrastructure of the region along with favorable medical reimbursement policies regarding surgical procedures are likely to drive the regional market growth.

The major companies serving the global fluorescence-guided surgery system market include Hamamatsu Photonics K.K., Olympus Corp., Stryker Corp., Medtronic PLC, and Getinge AB, among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market.